Clinical Trial Update: Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study [Phase 4]

View source ↗

Summary

Phase 4 post-marketing commitment trial evaluating gabapentin enacarbil for adults with Restless Legs Syndrome has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: XenoPort, Inc. | Conditions: Restless Legs Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-11-17